Janus Henderson Global Life Sciences Fund

Frequently Asked Questions About JAGLX

What does JAGLX invest in?

The Janus Henderson Global Life Sciences Fund primarily focuses its investment strategy on companies operating within the life sciences field. Typically, at least 80% of its net assets (which includes any borrowed funds for investment) are allocated to firms that the portfolio manager believes exhibit a life sciences orientation. Additionally, as a fundamental investment principle, the fund generally commits a minimum of 25% of its total assets to businesses officially classified within the "life sciences" sector.

What is the expense ratio of JAGLX?

Janus Henderson Global Life Sciences Fund (JAGLX) charges an expense ratio of 0.92%. This is the annual fee deducted from fund assets to cover management and operations.

How big is JAGLX?

Janus Henderson Global Life Sciences Fund (JAGLX) manages $6.20B in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure — funds below ~$50M are at higher risk of liquidation.

Is JAGLX actively managed or an index fund?

JAGLX's management style is described in the fund's prospectus. See the description on the Summary tab for the published strategy.

When was JAGLX launched?

Janus Henderson Global Life Sciences Fund (JAGLX) launched in December 1998 and is managed by Janus Henderson.

How has JAGLX performed?

JAGLX's total return — price change plus reinvested distributions — is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon.